Can COVID-19 cause lasting heart changes in children - even after a mild case?
Yes.
A new peer-reviewed study followed kids after infection.
The shocking part? Just how many still show signs of heart dysfunction years later.🧵
Even in children who had mild COVID, researchers found measurable - and persistent changes in heart function and blood pressure.
These weren’t isolated cases.
Some of the effects were detectable years after infection.
The study followed 228 children (ages 1–18) with PCR-confirmed COVID-19 in Kazakhstan.
Follow-up occurred 24-36 months after infection (2023-2024).
There was also a matched control group of 172 children with respiratory symptoms but no COVID-19.
Long-term findings:
35% of children had heart rhythm abnormalities (sic!)
Shortened PQ
Prolonged QT
Extrasystoles
AV block (1st degree)
Sinus tachycardia
These are not subtle changes - and they’re objectively measurable.
The most affected were adolescents (ages 12–18), who often reported:
Fatigue
Chest pain
Low exercise tolerance
And a non-dipping blood pressure profile - meaning their blood pressure didn’t drop at night like it should.
Among 16–18 year olds, 83% had this pattern (sic!)
In
Non-dipping is a known risk factor for future hypertension and cardiovascular disease.
Antibody tests revealed something else:
IgG levels (immune response markers) were still dramatically elevated up to 3 years post-infection.
Adolescents averaged 480 g/L
Normal range in healthy kids: 14 g/L
This could signal persistent immune activation - or viral antigen persistence. Both are concerning.
Eechocardiograms found structural changes in some kids:
Mitral valve prolapse
Mild regurgitation
Left ventricular enlargement
These changes were not always symptomatic - but they matter.
Blood tests for pro-BNP (a heart stress marker) were normal for most, but elevated in a few children, even without symptoms (sic)
That might suggest early or subclinical cardiac strain - invisible to the naked eye.
Bottom line:
Even mild COVID can leave behind permanent changes in children’s cardiovascular systems.
These effects are measurable and in some cases functionally relevant, especially in teenagers.
And here’s the key point:
These weren’t rare findings.
1 in 3 children had ECG abnormalities
Most adolescents had non-dipping blood pressure
Nearly all had elevated IgG years after infection
This is not anecdotal. This is population-level impact.
Conclusion:
The idea that COVID is no big deal for kids simply doesn’t hold up anymore.
Even when acute illness is mild, the long-term effects on the heart, blood pressure, and immune system should not be ignored.
Children deserve transparency. And follow-up care.
A widespread biological imprint that public health has largely ignored.
Kim et al. (2025). Clinical and Functional Characteristics of Cardiovascular System in Children Who Have Undergone COVID-19. Int Cardiovasc Res J. brieflands.com/articles/ircrj…
/We’re still underestimating SARS-CoV-2’s capacity to cause chronic physiological change.
Just because COVID is common doesn’t mean it’s harmless - especially after repeat exposures.
Think in terms of dose + duration + immune history.
Parallels between HIV and SARS-CoV-2?
It’s not about the viruses being the same.
It’s about how both can leave behind persistent, measurable damage - especially to the immune and cardiovascular systems, even without severe acute illness.
Both HIV and SARS-CoV-2 are RNA viruses with profound effects on the host immune system.
But unlike short-lived respiratory viruses, they leave long-lasting biological imprints.
Even after mild COVID, we now see:
Cardiac changes
Autonomic dysfunction
Persistent immune activation
Non-dipping blood pressure - seen in 83% of adolescents post-COVID - is also common in HIV patients, and linked to autonomic dysfunction.
It reflects disrupted circadian control of vascular tone, with long-term implications.
Chronic IgG elevation (anti-spike) post-COVID resembles immune overactivation seen in HIV.
This suggests:
Delayed immune resolution
Potential antigen persistence
Risk of immune exhaustion
None of this is just a cold behavior.
Both viruses can trigger neuroimmune dysregulation.
HIV: cognitive impairment, autonomic dysfunction
SARS-CoV-2: POTS, fatigue, brain fog, ME/CFS-like profiles
In both cases, immunologic low-grade dysfunction drives chronic symptoms.
Mitochondrial dysfunction is a shared feature:
HIV affects mitochondrial DNA and function in immune cells.
SARS-CoV-2 has been shown to cause respiratory chain disruption in monocytes, heart, and brain cells - even after recovery.
And when it comes to children, these lessons are urgent.
Because unlike with HIV, we’re letting this virus spread freely in pediatric populations, often without long-term monitoring or support.
Children deserve better than wait and see.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
What do we really know about COVID-19 vaccines and long COVID?
A meta-analysis from Robert Koch Institute analyzes 65 studies (5.7M people) to answer one critical question:
Do vaccines reduce the risk of long COVID when given before infection?
Short answer: Yes - but two key problems remain.🧵
Post-COVID condition (PCC; symptoms ≥3 months):
Vaccine effectiveness (VE): 41% (95% CI: 27.8–51.7%)
Long COVID (LC; symptoms ≥4 weeks):
VE: 34.1% (95% CI: 25.0–42.2%)
Effectiveness increased with dose count:
1 dose: 19%
2 doses: 43%
3 doses: 70% (based on one study)
Lower VE was observed:
in children (26%)
after Omicron infection: only 21% (CI –10% to +43%) - based on just two studies, but suggests that vaccines may be far less protective against long COVID after Omicron - especially in younger or previously exposed populations.
But two key factors limit how we interpret this data:
How long does protection last?
All included studies looked at vaccination before infection - but none analyzed VE as a function of time since vaccination.
We still don’t know if vaccines protect against long COVID 6 or more months after administration.
And that’s a major policy blind spot.
This lack of temporal analysis was explicitly acknowledged as a limitation by the authors.
What if long COVID (and ME/CFS) aren’t just consequences of damage or infection - but symptoms of a survival program that never shut off?
A new review in Cell Reports Medicine, 2025 says:
These conditions might be stuck in an ancient biological response.
Let’s unpack that. 🧵
The idea sounds bold, but it’s well grounded.
Komaroff and Dantzer suggest that many long COVID symptoms reflect a deeply wired program - the same one that makes us rest, isolate, and lose appetite when we’re sick.
In other words: this isn’t dysfunction only. It’s function gone chronic.
First, the biology. Long COVID and ME/CFS share striking patterns
Brain inflammation (shown by PET/MRS)
Endothelial dysfunction & leaky brain barriers
Autoantibodies targeting neuronal receptors
Mitochondrial stress, low ATP
Redox imbalance: too many oxidants, too few antioxidants
Low cortisol, autonomic dysfunction
Dysbiosis, gut leak, reactivated EBV/HHV6
None of this is hypothetical. It’s been replicated across studies and cohorts.
Pediatric immunity after COVID-19: new evidence of antibody dysfunction and autoimmunity.
A new study from the US shows that even mild SARS-CoV-2 infection in children can leave behind an immune imprint - including the production of autoantibodies and impaired antibody function.🧵
Researchers analyzed 139 children with various clinical presentations - from asymptomatic and mild cases, to severe COVID-19 and MIS-C. They compared them to 28 healthy controls.
More than half of the infected children had detectable autoantibodies. In healthy kids? Just 14%! That’s a strong signal.
What’s more - autoantibodies weren’t limited to the sickest children.
Even those with mild outpatient infections had similar rates of autoimmune reactivity. Some even developed antibodies linked to type 1 diabetes (like anti-IA2).
This suggests that even mild infection may shift immune tolerance.
New study confirms a key Long COVID immune signature:
shift toward Th2 and Th17 T cell responses
immune imbalance
thymus reactivation
The title says “recovery” - but 1 in 3 had persistent symptoms.
And they showed the clearest immune disruption.🧵
Researchers analyzed blood samples from people with:
acute COVID
past COVID
Long COVID
healthy controls
They profiled T cell subsets (CD4, CD8, memory states)
And crucially - they measured TREC, a marker of thymic activity.
In Long COVID, they found:
more Th2 and Th17 cells
fewer Tfh cells (help B cells make antibodies)
fewer effector CD8+ T cells
more naive T cells
and increased TREC = active thymus
This is not what recovery looks like. It’s a sign the immune system is still trying to fix something.
Tired months after COVID?
A study found that even 11 months later, many people still show impaired mitochondrial function in their immune cells - a possible driver of long COVID symptoms.
And yes, even after mild infections.🧵
Researchers measured mitochondrial membrane potential (ΔΨm) - a key indicator of cellular energy - in blood immune cells (PBMCs) from:
healthy controls
people with active COVID
recovered after 40 days (R1)
recovered after 11 months (R2)
The result?
ΔΨm was significantly reduced in all COVID groups - including R2, 11 months post-infection.
This suggests long-lasting mitochondrial stress, even after "mild" cases with no hospitalization.
A massive new study in Nature Communications (2025) looked at over 1.2 million kids and teens to answer a key question:
Does COVID-19 infection itself increase the risk of mental health problems in young people?
Short answer: Yes - slightly, but measurably.
Let’s break it down.🧵
The study followed children (5–11) and adolescents (12–20) across 25 major hospitals in the U.S., comparing
326,074 COVID+ patients
887,314 COVID− patients
All matched for background risk factors. Outcomes were tracked 1-6 months post-infection.
Kids who had COVID were slightly more likely to develop:
Anxiety
ADHD
Autism spectrum symptoms
OCD
Speech/communication disorders
Teens were also more likely to show:
Depression
Suicidal thoughts
Insomnia
Attention issues